Last updated on Oct 18, 2015
Get the free Form FDA 1571 - Investigational New Drug Application
We are not affiliated with any brand or entity on this form
Fill out
Complete the form online in a simple drag-and-drop editor.
eSign
Add your legally binding signature or send the form for signing.
Share
Share the form via a link, letting anyone fill it out from any device.
Export
Download, print, email, or move the form to your cloud storage.
Why pdfFiller is the best tool for your documents and forms
End-to-end document management
From editing and signing to collaboration and tracking, pdfFiller has everything you need to get your documents done quickly and efficiently.
Accessible from anywhere
pdfFiller is fully cloud-based. This means you can edit, sign, and share documents from anywhere using your computer, smartphone, or tablet.
Secure and compliant
pdfFiller lets you securely manage documents following global laws like ESIGN, CCPA, and GDPR. It's also HIPAA and SOC 2 compliant.
What is FDA 1571 IND
The Form FDA 1571 is a government document used by sponsors to submit an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA).
pdfFiller scores top ratings on review platforms
Who needs FDA 1571 IND?
Explore how professionals across industries use pdfFiller.
FDA 1571 IND is needed by:
-
Pharmaceutical Companies - Organizations developing new drugs for clinical trials.
-
Clinical Investigators - Professionals conducting research that involves new drug applications.
-
Regulatory Affairs Specialists - Experts responsible for ensuring compliance with FDA regulations.
-
Legal Representatives - Counsel assisting sponsors with regulatory submissions.
-
Healthcare Organizations - Institutions involved in clinical drug investigations.
Comprehensive Guide to FDA 1571 IND
What is Form FDA 1571 - Investigational New Drug Application?
Form FDA 1571 is a critical document used to submit an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA). This form is pivotal in the clinical trial process, enabling sponsors to gain the necessary approval to commence clinical investigations. The roles involved in this submission include the Sponsor, who is primarily responsible, the Authorized Representative, and the Countersigner, who may be required under specific circumstances, especially if the sponsor operates outside of the U.S.
Purpose and Benefits of Form FDA 1571
The primary purpose of filing Form FDA 1571 is to initiate the clinical investigation process for new drugs. Timely and accurate submission of this IND application form fosters regulatory compliance, increasing the likelihood of approval from the FDA. Conversely, neglecting to file the form can lead to significant setbacks, including delays in drug availability and legal repercussions for the involved parties.
Key Features of Form FDA 1571
Form FDA 1571 comprises several essential fields that facilitate the submission of vital information regarding the clinical trial. Key components include:
-
Sponsor information, including name and address
-
Drug details, encompassing the IND number and indication for use
-
Phase of clinical investigation, which informs the regulatory context
-
Signature requirements that confirm the authenticity of submissions
Each section of this clinical trial IND form holds significant importance, impacting the overall regulatory review process.
Who Needs to Use Form FDA 1571?
Various stakeholders are required to use Form FDA 1571, primarily sponsors and pharmaceutical companies involved in clinical investigations. Eligibility criteria may vary, but generally encompass organizations or individuals intending to test new drug formulations. Additionally, designated individuals may need to act as a countersigner, ensuring that all submissions are valid and recognized.
How to Fill Out Form FDA 1571 Online
Completing Form FDA 1571 online can streamline the process and enhance accuracy. Follow these steps to efficiently fill out the form:
-
Gather all necessary information, including sponsor and drug details.
-
Access the online platform to fill in each specific section of the form.
-
Utilize digital tools for completing fields and incorporating eSignatures.
Leveraging online tools can significantly ease the completion of the form and ensure all requisite information is captured accurately.
Submission Method for Form FDA 1571
Proper submission of Form FDA 1571 is essential for compliance. There are two primary options for submitting the form:
-
Online submission via the FDA's designated platform
-
Paper submission, where physical copies are sent via mail
Maintaining records of the submission, including receipt confirmations, is crucial, as is adhering to any specified deadlines related to submissions.
Common Errors and How to Avoid Them
While completing Form FDA 1571, several common errors can arise, potentially jeopardizing the application. Frequent mistakes include:
-
Incomplete sponsor or drug information
-
Incorrect signature placements
To mitigate these risks, it's advisable to conduct a thorough validation and review of all entries before submission. Utilizing a validation checklist can also ensure completeness and accuracy.
Security and Compliance for Form FDA 1571
Security measures are paramount when handling Form FDA 1571, especially given the sensitive nature of the information contained within. Organizations should ensure that:
-
Data is encrypted to protect against unauthorized access
-
All submissions comply with relevant regulatory requirements, such as HIPAA and GDPR
Prioritizing data protection throughout the submission process safeguards both the submitter and the integrity of the investigation.
Get Started with pdfFiller for Form FDA 1571
pdfFiller simplifies the process of filling out and submitting Form FDA 1571 by providing user-friendly services. Key features include:
-
eSignature capabilities for swift approvals
-
Document management tools to keep all submissions organized
-
Robust security protocols that protect sensitive information
By utilizing pdfFiller, users can experience a smooth and secure approach to managing their forms, ensuring that all submissions adhere to regulatory standards.
How to fill out the FDA 1571 IND
-
1.Access the Form FDA 1571 on pdfFiller by entering the document name in the search bar on the platform.
-
2.Open the form and familiarize yourself with the layout, noticing the required fields highlighted for easy navigation.
-
3.Before filling in the form, gather all necessary information, including the sponsor's details, drug information, IND number, indication for use, and product phases.
-
4.Begin by entering the sponsor's name and address in the designated fields. Ensure that the details are accurate to avoid delays.
-
5.Fill out the drug information section, entering the name(s) of the drug, IND number, and indication for use precisely.
-
6.Navigate to the submission details section and provide accurate details regarding the phase of the clinical investigation.
-
7.Ensure that the signature fields are properly completed. The form must be signed by the sponsor or an authorized representative.
-
8.After filling in all fields, carefully review the entire document for any inaccuracies or missing information.
-
9.Once satisfied, save your changes. Use the options available on pdfFiller to save the form to your device or submit it directly if available.
-
10.If needed, download a copy of the completed form for your records after successful submission.
Who is eligible to submit Form FDA 1571?
Form FDA 1571 can be submitted by sponsors of clinical investigations, such as individuals, pharmaceutical companies, or organizations conducting research involving new drugs.
What supporting documents are needed with the form?
Along with Form FDA 1571, sponsors may need to submit additional documents such as protocols for the clinical study, investigator brochures, and any prior correspondence with the FDA regarding the IND.
What are the potential common mistakes when filling out this form?
Common mistakes include providing incomplete information, missing signatures, or incorrect drug details. Ensure all fields are filled accurately to avoid submission delays.
How is the FDA 1571 form submitted?
The form can be submitted electronically via the FDA's submission portal or submitted by mail. Ensure you check for the latest guidelines on submission methods.
What is the processing time for an IND application?
Processing times can vary. Typically, the FDA reviews IND applications within 30 days. However, more complex submissions may take longer.
Is notarization required for this form?
No, notarization is not required for Form FDA 1571, although proper signatures are essential for the form's validity.
Can multiple sponsors sign the FDA 1571 form?
Yes, multiple sponsors can be involved. However, only one sponsor or their authorized representative must sign the form, with additional countersignatures if applicable.
Related Forms
If you believe that this page should be taken down, please follow our DMCA take down process
here
.
This form may include fields for payment information. Data entered in these fields is not covered by PCI DSS compliance.